XN4.F BIG PHARMA SPLIT CL.A
- Market cap
- EUR 12.6M
- P/E
- -
- P/B
- 1.04x
- ROE
- 27.5%
- Dividend yield
- 10.98%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is XN4.F undervalued?
Graham numberThe Graham number of BIG PHARMA SPLIT CL.A cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BIG PHARMA SPLIT CL.A fundamental analysis
No fundamental analysis for BIG PHARMA SPLIT CL.A yet.
BIG PHARMA SPLIT CL.A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BIG PHARMA SPLIT CL.A
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Full company profileBIG PHARMA SPLIT CL.A financial statements
BIG PHARMA SPLIT CL.A annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 5.36M | 3.71M | 307K | 436K | 5.55M |
| Net Income | 4.85M | 3.15M | -145K | 13.4K | 5.03M |
| EPS | 3.27 | 2.46 | -0.12 | 0.01 | 3.86 |
| Balance Sheet | |||||
| Total Assets | 37.8M | 39.1M | 26.5M | 26.3M | 31.8M |
| Total Liabilities | 15.4M | 19.4M | 10.7M | 12.6M | 13.6M |
| Shareholders' Equity | 22.4M | 19.7M | 15.9M | 13.7M | 18.3M |
| Cash & Short-term Investments | 1.43M | 819K | 204K | 1.03M | 1.35M |
| Cash Flow | |||||
| Operating Cash Flow | -9.00M | 1.13M | 11.9M | 1.71M | -890K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -9.00M | 1.13M | 11.9M | 1.71M | -890K |
| Ratios | |||||
| ROE | 21.7% | 15.9% | -0.9% | 0.1% | 27.5% |
| ROA | 12.8% | 8.0% | -0.5% | 0.1% | 15.8% |
| Net Profit Margin | 90.6% | 84.8% | -47.3% | 3.1% | 90.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BIG PHARMA SPLIT CL.A dividends
- Dividend yield
- 10.98%
- Forward dividend
- 0.76 EUR
- Payout ratio
- 42.1%
- Ex-dividend date
- Sep 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CAD 2.12M | 1.62 | 42.1% |
| 2024 | CAD 2.04M | 1.76 | 15,213.8% |
| 2023 | CAD 2.11M | 1.81 | - |
| 2022 | CAD 2.62M | 2.04 | 83.2% |
| 2021 | CAD 2.84M | 1.91 | 58.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns BIG PHARMA SPLIT CL.A
Ownership data of BIG PHARMA SPLIT CL.A is not available yet.
BIG PHARMA SPLIT CL.A company profile
- Company name
- BIG PHARMA SPLIT CL.A
- Ticker
- XN4.F
- ISIN
- CA08934P1080
- Exchange
- Frankfurt Exchange
- Sector
- Financial Services
- Industry
- Capital Markets
- Fiscal year end
- December
- Address
- 610 Chartwell Road, Oakville, ON, Canada, L6j 4A5
- Phone
- 416-649-4541
About BIG PHARMA SPLIT CL.A
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.